Thiophosgene → HCID 25235305, compound
Reaction equation
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([F:11])([F:10])[F:9])=[CH:4][N:3]=1.[C:12](Cl)(Cl)=S.[Cl:16][C:17]1[CH:22]=[CH:21][CH:20]=[C:19]([Cl:23])[C:18]=1[C:24]1[NH:25][C:26]2[CH:32]=[C:31]([C:33]([NH:35][NH2:36])=[O:34])[CH:30]=[CH:29][C:27]=2[N:28]=1.CCN=C=NCCCN(C)C>C(Cl)(Cl)Cl.C([O-])(O)=O.[Na+].CCOC(C)=O>[Cl:16][C:17]1[CH:22]=[CH:21][CH:20]=[C:19]([Cl:23])[C:18]=1[C:24]1[NH:25][C:26]2[CH:32]=[C:31]([C:33]3[O:34][C:12]([NH:1][C:2]4[CH:7]=[CH:6][C:5]([C:8]([F:9])([F:11])[F:10])=[CH:4][N:3]=4)=[N:36][N:35]=3)[CH:30]=[CH:29][C:27]=2[N:28]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
Dissolve 2-amino-5-trifluoromethyl-pyridine (164 mg, 1.01 mmol) in a biphasic solution of CHCl3 (25 mL) and saturated NaHCO3 (25 mL). Add thiophosgene (78 uL, 1.01 mmol) to the organic phase and stir the reaction vigorously for 2.5 hr. Separate the phases and extract the aqueous phase with CHCl3 (25 mL). Concentrate the combined organics and take the concentrate up in DMF (3 mL). Add 2-(2,6-dichloro-phenyl)-3H-benzoimidazole-5-carboxylic acid hydrazide (250 mg, 0.778 mmol) and stir overnight. Add EDCI (298 mg, 1.56 mmol) and heat to 80° C. for 4 hr. Upon cooling to room temp dilute the reaction with EtOAc (75 mL) and extract with water (15 mL). Dry the organic phase over Na2SO4 and concentrate. Purify the concentrate by reverse phase HPLC (35-50% ACN/H2O+5 mM NH4OH) to afford the title compound as a cream colored solid: 1H NMR (400 MHz, DMSO-d6) δ ppm 7.63-7.68 (m, 1H) 7.70 (s, 1H) 7.72 (d, J=1.77 Hz, 1H) 7.76-7.87 (m, 1H) 7.88-7.94 (m, 1H) 8.04-8.30 (m, 3H) 8.72 (br. s., 1H) 11.87 (br. s., 1H) 13.31 (br. s., 1H); MS m/z=491.8 (M+1).
Workup
- customthe reaction vigorously for 2.5 hr
- customSeparate the phases
- extractionextract the aqueous phase with CHCl3 (25 mL)
- concentrationConcentrate the combined organics and
- concentrationconcentrate up in DMF (3 mL)
- additiondilute
- extractionextract with water (15 mL)
- dry with materialDry the organic phase over Na2SO4
- concentrationconcentrate
- customPurify the
- concentrationconcentrate by reverse phase HPLC (35-50% ACN/H2O+5 mM NH4OH)
Sources & evidence
- ORD record
- ord-fc5ea40eab25425386c6f0f0157dfd2c
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07879850B2
Reaction notes
Loading…